Sorry, you need to enable JavaScript to visit this website.

SUTENT (sunitinib capsules) Contraindications

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.


Use of SUTENT (sunitinib malate) is contraindicated in patients with hypersensitivity to sunitinib malate or to any other component of SUTENT. For a complete listing, see the Dosage Forms, Composition and Packaging sections of the Product Monograph.

SUTENT is contraindicated in pregnant women.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111